521 related articles for article (PubMed ID: 26014049)
21. Severe Radiation Necrosis Refractory to Surgical Resection in Patients with Melanoma and Brain Metastases Managed with Ipilimumab/Nivolumab and Brain-Directed Stereotactic Radiation Therapy.
Shi DD; Arnaout O; Bi WL; Buchbinder EI; Cagney DN; Insco ML; Liu D; Schoenfeld JD; Aizer AA
World Neurosurg; 2020 Jul; 139():226-231. PubMed ID: 32330622
[TBL] [Abstract][Full Text] [Related]
22. Radiosurgery/stereotactic radiotherapy in combination with immunotherapy and targeted agents for melanoma brain metastases.
Trino E; Mantovani C; Badellino S; Ricardi U; Filippi AR
Expert Rev Anticancer Ther; 2017 Apr; 17(4):347-356. PubMed ID: 28277101
[TBL] [Abstract][Full Text] [Related]
23. Current Treatment of Melanoma Brain Metastasis.
Rishi A; Yu HM
Curr Treat Options Oncol; 2020 Apr; 21(6):45. PubMed ID: 32350685
[TBL] [Abstract][Full Text] [Related]
24. Update on the role of ipilimumab in melanoma and first data on new combination therapies.
Maio M; Di Giacomo AM; Robert C; Eggermont AM
Curr Opin Oncol; 2013 Mar; 25(2):166-72. PubMed ID: 23299197
[TBL] [Abstract][Full Text] [Related]
25. Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab.
Frenard C; Peuvrel L; Jean MS; Brocard A; Knol AC; Nguyen JM; Khammari A; Quereux G; Dreno B
J Neurooncol; 2016 Jan; 126(2):355-60. PubMed ID: 26511495
[TBL] [Abstract][Full Text] [Related]
26. Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 2: Existing Experience and Considerations for Future Trials.
Zhang I; Formenti SC; Knisely JPS
Oncology (Williston Park); 2018 Mar; 32(3):e33-e37. PubMed ID: 29548066
[TBL] [Abstract][Full Text] [Related]
27. Ipilimumab in advanced melanoma: reports of long-lasting responses.
Farolfi A; Ridolfi L; Guidoboni M; Nicoletti SV; Piciucchi S; Valmorri L; Costantini M; Scarpi E; Amadori D; Ridolfi R
Melanoma Res; 2012 Jun; 22(3):263-70. PubMed ID: 22516968
[TBL] [Abstract][Full Text] [Related]
28. Severe thromboembolic phenomenon in the setting of pseudoprogression of melanoma brain metastases in response to combination immunotherapy.
Perez MC; Yu HM; Markowitz J
BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30108120
[TBL] [Abstract][Full Text] [Related]
29. New Era in the Management of Melanoma Brain Metastases.
Tawbi HA; Boutros C; Kok D; Robert C; McArthur G
Am Soc Clin Oncol Educ Book; 2018 May; 38():741-750. PubMed ID: 30231345
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy Plus Stereotactic Radiosurgery: Building on the Promise of Precision Medicine for CNS Malignancies-PART 1: Principles of Combined Treatment.
Zhang I; Formenti SC; Knisely JPS
Oncology (Williston Park); 2018 Feb; 32(2):e28-e32. PubMed ID: 29492951
[TBL] [Abstract][Full Text] [Related]
31. Ipilimumab and whole brain radiation therapy for melanoma brain metastases.
Gerber NK; Young RJ; Barker CA; Wolchok JD; Chan TA; Yamada Y; Friguglietti L; Beal K
J Neurooncol; 2015 Jan; 121(1):159-65. PubMed ID: 25273687
[TBL] [Abstract][Full Text] [Related]
32. Advances in the systemic treatment of melanoma brain metastases.
Glitza Oliva IC; Schvartsman G; Tawbi H
Ann Oncol; 2018 Jul; 29(7):1509-1520. PubMed ID: 29790899
[TBL] [Abstract][Full Text] [Related]
33. Current and emerging options for patients with melanoma brain metastases.
Kreidieh FY; Tawbi HA
Clin Adv Hematol Oncol; 2022 Oct; 20(10):619-627. PubMed ID: 36206074
[TBL] [Abstract][Full Text] [Related]
34. Treatment of brain metastases from melanoma.
McWilliams RR; Brown PD; Buckner JC; Link MJ; Markovic SN
Mayo Clin Proc; 2003 Dec; 78(12):1529-36. PubMed ID: 14661682
[TBL] [Abstract][Full Text] [Related]
35. Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy.
Stokes WA; Binder DC; Jones BL; Oweida AJ; Liu AK; Rusthoven CG; Karam SD
J Neuroimmunol; 2017 Dec; 313():118-122. PubMed ID: 29153603
[TBL] [Abstract][Full Text] [Related]
36. The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy.
Kaidar-Person O; Zagar TM; Deal A; Moschos SJ; Ewend MG; Sasaki-Adams D; Lee CB; Collichio FA; Fried D; Marks LB; Chera BS
Anticancer Drugs; 2017 Jul; 28(6):669-675. PubMed ID: 28368903
[TBL] [Abstract][Full Text] [Related]
37. [Systemic treatment of melanoma brain metastases].
Le Rhun É; Mateus C; Mortier L; Dhermain F; Guillot B; Grob JJ; Lebbe C; Thomas M; Jouary T; Leccia MT; Robert C
Cancer Radiother; 2015 Feb; 19(1):48-54. PubMed ID: 25656856
[TBL] [Abstract][Full Text] [Related]
38. Immune Checkpoint Inhibitors for Brain Metastases.
Tan AC; Heimberger AB; Menzies AM; Pavlakis N; Khasraw M
Curr Oncol Rep; 2017 Jun; 19(6):38. PubMed ID: 28417311
[TBL] [Abstract][Full Text] [Related]
39. Melanoma in the brain: biology and therapeutic options.
Gibney GT; Forsyth PA; Sondak VK
Melanoma Res; 2012 Jun; 22(3):177-83. PubMed ID: 22495668
[TBL] [Abstract][Full Text] [Related]
40. Metastatic melanoma to the brain: surgery and radiation is still the standard of care.
Nicholas S; Mathios D; Jackson C; Lim M
Curr Treat Options Oncol; 2013 Jun; 14(2):264-79. PubMed ID: 23504304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
